| 000 | 01622 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513202734.0 | ||
| 264 | 0 | _c20000323 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0017-5749 | ||
| 024 | 7 |
_a10.1136/gut.46.3.427 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMuñoz, A E | |
| 245 | 0 | 0 |
_aInterferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial. _h[electronic resource] |
| 260 |
_bGut _cMar 2000 |
||
| 300 |
_a427-31 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aKetoprofen _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aLevi, D | |
| 700 | 1 | _aPodestá, A | |
| 700 | 1 | _aGorín, J M | |
| 700 | 1 | _aGonzález, J | |
| 700 | 1 | _aBartellini, M A | |
| 700 | 1 | _aMunne, M S | |
| 700 | 1 | _aCabanne, A | |
| 700 | 1 | _aFlichman, D | |
| 700 | 1 | _aTerg, R | |
| 773 | 0 |
_tGut _gvol. 46 _gno. 3 _gp. 427-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.46.3.427 _zAvailable from publisher's website |
| 999 |
_c10627697 _d10627697 |
||